MarketCap
Facebook
X
TelegramQuartalsbericht 2024-Q2
hinzugefügt 01.08.2024
Bausch Health Companies DIO 2011-2026 | BHC
DIO Jährlich Bausch Health Companies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 172 | 145 | 150 | 148 | 177 | 154 | 169 | 187 | 178 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 187 | 145 | 165 |
DIO anderer Aktien in der Arzneimittelhersteller
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aerie Pharmaceuticals
AERI
|
459 | - | - | $ 754 M |  USA |
 |
AcelRx Pharmaceuticals
ACRX
|
133 | - | 7.5 % | $ 6.35 M | USA |
 |
Catalent
CTLT
|
71.9 | - | - | $ 11.5 B | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
48.9 | - | 0.86 % | $ 117 M | USA |
 |
DURECT Corporation
DRRX
|
460 | - | - | $ 50.1 M | USA |
 |
Canopy Growth Corporation
CGC
|
167 | $ 1.1 | 4.05 % | $ 118 M |  Canada |
 |
Endo International plc
ENDP
|
100 | - | - | $ 28.9 M |  Irlanda |
 |
Agile Therapeutics
AGRX
|
82.7 | - | 10.11 % | $ 58.2 M | USA |
 |
Evoke Pharma
EVOK
|
995 | - | - | $ 36.6 M | USA |
 |
Alimera Sciences
ALIM
|
58.7 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
221 | $ 2.67 | 2.69 % | $ 1.38 B | Canada |
 |
Evolus
EOLS
|
71.3 | $ 5.45 | 31.84 % | $ 351 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
366 | - | - | $ 2.06 B |  France |
 |
Jupiter Wellness
JUPW
|
59.7 | - | - | $ 33.6 M | USA |
 |
China Pharma Holdings
CPHI
|
168 | $ 0.58 | 2.89 % | $ 10.1 M |  China |
 |
Cumberland Pharmaceuticals
CPIX
|
239 | $ 4.06 | -11.35 % | $ 57.1 M | USA |
 |
HEXO Corp.
HEXO
|
703 | - | 2.45 % | $ 38.1 M | Canada |
 |
Harrow Health
HROW
|
65.1 | $ 39.71 | 2.86 % | $ 1.46 B | USA |
 |
Aurora Cannabis
ACB
|
1.35 K | $ 3.67 | 5.32 % | $ 86.3 M | Canada |
 |
Athenex
ATNX
|
158 | - | -23.39 % | $ 1.76 M | USA |
 |
Emergent BioSolutions
EBS
|
176 | $ 8.78 | -1.46 % | $ 450 M | USA |
 |
ProPhase Labs
PRPH
|
30.1 | - | - | $ 5.07 M | USA |
 |
Assertio Holdings
ASRT
|
347 | $ 12.06 | 1.39 % | $ 857 M | USA |
 |
Radius Health
RDUS
|
204 | - | - | $ 1.42 B | USA |
 |
Lannett Company
LCI
|
127 | - | 1.15 % | $ 7.11 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
149 | - | -39.89 % | $ 27.7 M | USA |
 |
Organogenesis Holdings
ORGO
|
85.9 | $ 2.95 | 2.79 % | $ 388 M | USA |
 |
OrganiGram Holdings
OGI
|
2.83 K | $ 1.4 | 2.19 % | $ 402 M | Canada |
 |
Perrigo Company plc
PRGO
|
148 | $ 11.62 | 2.06 % | $ 1.61 B | USA |
 |
Rockwell Medical
RMTI
|
28.5 | $ 0.9 | -0.17 % | $ 21 M | USA |
 |
TherapeuticsMD
TXMD
|
1.04 K | $ 2.23 | 0.23 % | $ 23.3 M | USA |
 |
Veru
VERU
|
179 | $ 2.6 | 3.17 % | $ 351 M | USA |
 |
Viatris
VTRS
|
140 | $ 14.7 | -1.28 % | $ 17.6 B | USA |
 |
Pacira BioSciences
PCRX
|
246 | $ 22.8 | 3.17 % | $ 1.05 B | USA |
 |
PetIQ
PETQ
|
64.9 | - | 1.64 % | $ 400 M | USA |
 |
OptiNose
OPTN
|
370 | - | - | $ 1.08 B | USA |
 |
PLx Pharma
PLXP
|
97.2 | - | -27.8 % | $ 2.56 M | USA |
 |
Recro Pharma
REPH
|
49.1 | - | -4.76 % | $ 65.3 M | USA |
 |
cbdMD
YCBD
|
165 | $ 0.77 | -1.53 % | $ 3.32 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
117 | $ 2.69 | -2.18 % | $ 3.34 M | USA |
 |
Tilray
TLRY
|
170 | $ 7.49 | 1.77 % | $ 4.63 B | Canada |